Blog

The Race for the Cure is coming to Eugene – 10.10.10, Autzen Stadium, Eugene

There’s quite a bit of pink popping up around CAWOOD lately – and it’s not just the blooming tulips kind of pink. Our team is lending its marketing skills to the inaugural 2010 Komen Eugene Race for the Cure. As part of our pro bono effort, we’re working hard to develop a unique identity for the Eugene Race and get the word out however we can.

In a town already known for its running events, it’s natural to ask, "Why Komen? Why Race for the Cure? Why the focus on breast cancer?" A lot of us at CAWOOD asked the same questions.

And the answers were a bit surprising. For instance, did you know that the Pacific Northwest has the highest incidence of breast cancer in the nation? Or that more than 34,000 women in Lane County are currently uninsured and missing important annual health screenings, such as mammograms? Or, even more chilling: Lane County’s rate of late-stage breast cancer diagnosis is higher than the state average – those cancers that are harder to treat and more difficult to survive.

The women in this community deserve better.

The Susan G. Komen Foundation is already hard at work, here, in Lane County, providing free screenings to low-income women. But they need our support to do even more. Seventy-five percent of funds raised from the Race stay in Oregon and help women.

In addition to leading the marketing efforts, CAWOOD is sponsoring its own team for the Race, happening Oct. 10, 2010 at Autzen Stadium. We welcome you to join our team, or support our fundraising efforts. We’ve got a couple of wacky ideas in the works, so stay tuned!

And if you know a breast cancer survivor who would like to share her story, please steer her our direction. It’s important for women in our community to understand the benefits of annual screening. One woman’s story could save another woman’s life. Also, be sure to invite her to the Race, where breast cancer survivors are the guests of honor.

Join the movement to end breast cancer forever.